Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Biosimilar Contract Manufacturing Global Market Report 2025
Download Free Sample Buy Now
Global Biosimilar Contract Manufacturing Market Report 2025

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Biosimilar Contract Manufacturing Global Market Report 2025

By Product Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor, Other Product Types), By Service Type (Process Development, Analytical And Quality Control, Fill And Finish Operations, Packaging, Other Service Types), By Source (Mammalian, Non-mammalian), By Application (Oncology, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications), By End-Use (Pharmaceutical Companies, Biotech Companies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biosimilar Contract Manufacturing Market Overview

• Biosimilar Contract Manufacturing market size has reached to $8.58 billion in 2024

• Expected to grow to $17.66 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%

• Growth Driver: Growing Prevalence Of Diabetes Fueling The Growth Of The Market Due To Rising Demand For Affordable Insulin And Biologic Therapies

• Market Trend: Single-Use Biomanufacturing Reduces Costs And Shortens Production Timelines

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biosimilar Contract Manufacturing Market?

Biosimilar contract manufacturing refers to the outsourcing of biosimilar drug production to specialized third-party manufacturers with advanced infrastructure, technical expertise, and regulatory experience. These manufacturers produce biosimilars, biologic medicines highly similar to approved reference biologics in terms of safety, efficacy, and quality. It enables biopharmaceutical companies to minimize production costs, ensure compliance, and accelerate time-to-market.

The main product types of biosimilar contract manufacturing are monoclonal antibodies, insulin, erythropoietin, granulocyte colony-stimulating factor, and others. Monoclonal antibodies refer to laboratory-made, highly specific proteins engineered to recognise and bind a single target (antigen) on cells or molecules, enabling precise diagnosis or therapy. They offer various services such as process development, analytical and quality control, fill and finish operations, packaging, and others with source systems, including mammalian and non-mammalian. It finds applications in oncology, autoimmune diseases, blood disorders, growth hormone deficiency, and other, serving end users such as pharmaceutical companies and biotech companies.

Biosimilar Contract Manufacturing Market Size and growth rate 2025 to 2029: Graph

What Is The Biosimilar Contract Manufacturing Market Size 2025 And Growth Rate?

The biosimilar contract manufacturing market size has grown rapidly in recent years. It will grow from $8.58 billion in 2024 to $9.94 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing patent expirations of reference biologics, rising healthcare cost containment by payers, growing acceptance of biosimilars among clinicians, increasing prevalence of chronic diseases, and rising demand for affordable biologic therapies.

What Is The Biosimilar Contract Manufacturing Market Growth Forecast?

The biosimilar contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $17.66 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing off-patent expiries of monoclonal antibodies, growing biosimilar development pipelines, rising price pressures and tender-based procurement, increasing adoption of value-based reimbursement, and growing entry of small and mid-sized biopharma sponsors. Major trends in the forecast period include a shift towards single-use bioreactor technology advancements, continuous bioprocessing developments, process analytical technology adoption and innovations, artificial intelligence and machine learning applications in bioprocess optimization, and quality by design implementation expansion.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Biosimilar Contract Manufacturing Market Segmented?

1) By Product Type: Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor, Other Product Types

2) By Service Type: Process Development, Analytical And Quality Control, Fill And Finish Operations, Packaging, Other Service Types

3) By Source: Mammalian, Non-mammalian

4) By Application: Oncology, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications

5) By End-Use: Pharmaceutical Companies, Biotech Companies

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies, Bispecific Monoclonal Antibodies

2) By Insulin: Rapid Acting Insulin, Short Acting Insulin, Intermediate Acting Insulin, Long Acting Insulin, Premixed Insulin

3) By Erythropoietin: Alpha Erythropoietin, Beta Erythropoietin, Darbepoetin Alfa, Continuous Erythropoietin Receptor Activators

4) By Granulocyte Colony-Stimulating Factor: Filgrastim, Pegfilgrastim, Lenograstim, Long Acting Granulocyte Colony-Stimulating Factor

5) By Other Product Types: interferons, Interleukins, Fusion Proteins, Enzyme Therapeutics, Hormonal Biologics

What Is Driving The Biosimilar Contract Manufacturing Market? Growing Prevalence Of Diabetes Fueling The Growth Of The Market Due To Rising Demand For Affordable Insulin And Biologic Therapies

The growing prevalence of diabetes is expected to propel the growth of the biosimilar contract manufacturing market going forward. Diabetes prevalence refers to the proportion of people in a population living with diabetes at a given time, reflecting ongoing treatment need and lifetime therapy demand. The rise in diabetes prevalence is due to increasing sedentary lifestyles and poor dietary habits that lead to obesity, insulin resistance, and higher rates of type 2 diabetes. Biosimilar contract manufacturing supports diabetes management by enabling the large-scale, cost-effective production of biosimilar insulin and related biologics. It ensures consistent quality and regulatory compliance, making advanced therapies more accessible to patients. This improves treatment affordability and enhances global access to essential diabetes care. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of diabetes is driving the growth of the biosimilar contract manufacturing industry.

Who Are The Major Players In The Global Biosimilar Contract Manufacturing Market?

Major companies operating in the biosimilar contract manufacturing market are Thermo Fisher Scientific Inc., Biocon Limited, Lonza Group AG, Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., Laboratorios Farmacéuticos Rovi S.A., Vetter Pharma-Fertigung GmbH & Co. KG, National Resilience Inc., Porton Pharma Solutions Co. Ltd., Syngene International Limited, Rentschler Biopharma SE, Boehringer Ingelheim International GmbH, Enzene Biosciences Ltd., Prestige Biologics Co. Ltd., Mabion S.A., HALIX B.V., BioConnection B.V., BioCina Pty Ltd, Mycenax Biotech Inc., Polpharma Biologics S.A.

What Are The Key Trends Of The Global Biosimilar Contract Manufacturing Market? Single-Use Biomanufacturing Reduces Costs And Shortens Production Timelines

Major companies operating in the biosimilar contract manufacturing market are focusing on developing production facilities, such as mirrored single-use plants, to accelerate tech transfer, scale-up, and commercial reliability. Mirrored single-use plants are facilities built with identical production suites that run on disposable bioprocess equipment and unified digital systems, enabling rapid changeovers, consistent quality across sites, and lower contamination risk. For instance, in September 2025, Rezon Bio, a Poland-based contract development and manufacturing organization (CDMO), launched two mirrored-capability single-use biomanufacturing sites covering cell line development through commercial GMP supply. This approach enables faster technology transfer and flexible scale-up for biosimilars with reduced downtime, while improving batch-to-batch consistency through standardized suites, integrated analytics, and logistics automation. It also lowers the total cost of ownership for sponsors by minimizing cleaning validation requirements, shortening development and manufacturing timelines, and de-risking expansion.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Biosimilar Contract Manufacturing Market? Advent And Warburg Acquire Baxter’s BioPharma Solutions To Expand Biologics Manufacturing Capabilities

In October 2023, Advent International Corporation, a US-based private equity firm, and Warburg Pincus LLC, a US-based private equity firm, acquired BioPharma Solutions' business (now Simtra BioPharma Solutions) from Baxter International Inc. for an undisclosed amount. With this acquisition, Advent International and Warburg Pincus aim to strengthen their presence in the biopharmaceutical manufacturing sector by leveraging BioPharma Solutions’ expertise in contract development and manufacturing of biologics and biosimilars, thereby supporting global demand for advanced biopharma production capabilities. Baxter International Inc. is a US-based biotechnology company that provides biosimilar contract manufacturing services.

What Is The Regional Outlook For The Global Biosimilar Contract Manufacturing Market?

North America was the largest region in the biosimilar contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biosimilar Contract Manufacturing Market?

The biosimilar contract manufacturing market consists of revenues earned by entities by providing services such as cell line development, process optimization, upstream and downstream processing, formulation, fill-finish, quality control, packaging, and regulatory support. The market value includes the value of related goods sold by the service provider or included within the service offering. The biosimilar contract manufacturing market also includes sales of biosimilar drug substances, intermediates, active pharmaceutical ingredients (APIs), finished dosage forms, cell culture media, single-use bioreactors, chromatography resins, filtration systems, and other bioprocessing consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biosimilar Contract Manufacturing Industry?

The biosimilar contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biosimilar contract manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Biosimilar Contract Manufacturing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $9.94 billion
Revenue Forecast In 2034 $17.66 billion
Growth Rate CAGR of 15.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Product Type, Service Type, Source, Application, End-Use
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific Inc., Biocon Limited, Lonza Group AG, Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., Laboratorios Farmacéuticos Rovi S.A., Vetter Pharma-Fertigung GmbH & Co. KG, National Resilience Inc., Porton Pharma Solutions Co. Ltd., Syngene International Limited, Rentschler Biopharma SE, Boehringer Ingelheim International GmbH, Enzene Biosciences Ltd., Prestige Biologics Co. Ltd., Mabion S.A., HALIX B.V., BioConnection B.V., BioCina Pty Ltd, Mycenax Biotech Inc., Polpharma Biologics S.A.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Biosimilar Contract Manufacturing Market Characteristics

3. Biosimilar Contract Manufacturing Market Trends And Strategies

4. Biosimilar Contract Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biosimilar Contract Manufacturing Growth Analysis And Strategic Analysis Framework

5.1. Global Biosimilar Contract Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biosimilar Contract Manufacturing Market Growth Rate Analysis

5.4. Global Biosimilar Contract Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biosimilar Contract Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biosimilar Contract Manufacturing Total Addressable Market (TAM)

6. Biosimilar Contract Manufacturing Market Segmentation

6.1. Global Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Insulin

Erythropoietin

Granulocyte Colony-Stimulating Factor

Other Product Types

6.2. Global Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Process Development

Analytical And Quality Control

Fill And Finish Operations

Packaging

Other Service Types

6.3. Global Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mammalian

Non-Mammalian

6.4. Global Biosimilar Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Autoimmune Diseases

Blood Disorders

Growth Hormone Deficiency

Other Applications

6.5. Global Biosimilar Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biotech Companies

6.6. Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chimeric Monoclonal Antibodies

Humanized Monoclonal Antibodies

Fully Human Monoclonal Antibodies

Bispecific Monoclonal Antibodies

6.7. Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rapid Acting Insulin

Short Acting Insulin

Intermediate Acting Insulin

Long Acting Insulin

Premixed Insulin

6.8. Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Erythropoietin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alpha Erythropoietin

Beta Erythropoietin

Darbepoetin Alfa

Continuous Erythropoietin Receptor Activators

6.9. Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Granulocyte Colony-Stimulating Factor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Filgrastim

Pegfilgrastim

Lenograstim

Long Acting Granulocyte Colony-Stimulating Factor

6.10. Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Interferons

Interleukins

Fusion Proteins

Enzyme Therapeutics

Hormonal Biologics

7. Biosimilar Contract Manufacturing Market Regional And Country Analysis

7.1. Global Biosimilar Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biosimilar Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biosimilar Contract Manufacturing Market

8.1. Asia-Pacific Biosimilar Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biosimilar Contract Manufacturing Market

9.1. China Biosimilar Contract Manufacturing Market Overview

9.2. China Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biosimilar Contract Manufacturing Market

10.1. India Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biosimilar Contract Manufacturing Market

11.1. Japan Biosimilar Contract Manufacturing Market Overview

11.2. Japan Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biosimilar Contract Manufacturing Market

12.1. Australia Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biosimilar Contract Manufacturing Market

13.1. Indonesia Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biosimilar Contract Manufacturing Market

14.1. South Korea Biosimilar Contract Manufacturing Market Overview

14.2. South Korea Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biosimilar Contract Manufacturing Market

15.1. Western Europe Biosimilar Contract Manufacturing Market Overview

15.2. Western Europe Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biosimilar Contract Manufacturing Market

16.1. UK Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biosimilar Contract Manufacturing Market

17.1. Germany Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biosimilar Contract Manufacturing Market

18.1. France Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biosimilar Contract Manufacturing Market

19.1. Italy Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biosimilar Contract Manufacturing Market

20.1. Spain Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biosimilar Contract Manufacturing Market

21.1. Eastern Europe Biosimilar Contract Manufacturing Market Overview

21.2. Eastern Europe Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biosimilar Contract Manufacturing Market

22.1. Russia Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biosimilar Contract Manufacturing Market

23.1. North America Biosimilar Contract Manufacturing Market Overview

23.2. North America Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biosimilar Contract Manufacturing Market

24.1. USA Biosimilar Contract Manufacturing Market Overview

24.2. USA Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biosimilar Contract Manufacturing Market

25.1. Canada Biosimilar Contract Manufacturing Market Overview

25.2. Canada Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biosimilar Contract Manufacturing Market

26.1. South America Biosimilar Contract Manufacturing Market Overview

26.2. South America Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biosimilar Contract Manufacturing Market

27.1. Brazil Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biosimilar Contract Manufacturing Market

28.1. Middle East Biosimilar Contract Manufacturing Market Overview

28.2. Middle East Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biosimilar Contract Manufacturing Market

29.1. Africa Biosimilar Contract Manufacturing Market Overview

29.2. Africa Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biosimilar Contract Manufacturing Market Competitive Landscape And Company Profiles

30.1. Biosimilar Contract Manufacturing Market Competitive Landscape

30.2. Biosimilar Contract Manufacturing Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Biocon Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Samsung Biologics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. WuXi Biologics (Cayman) Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biosimilar Contract Manufacturing Market Other Major And Innovative Companies

31.1. Laboratorios Farmacéuticos Rovi S.A.

31.2. Vetter Pharma-Fertigung GmbH & Co. KG

31.3. National Resilience Inc.

31.4. Porton Pharma Solutions Co. Ltd.

31.5. Syngene International Limited

31.6. Rentschler Biopharma SE

31.7. Boehringer Ingelheim International GmbH

31.8. Enzene Biosciences Ltd.

31.9. Prestige Biologics Co. Ltd.

31.10. Mabion S.A.

31.11. HALIX B.V.

31.12. BioConnection B.V.

31.13. BioCina Pty Ltd

31.14. Mycenax Biotech Inc.

31.15. Polpharma Biologics S.A.

32. Global Biosimilar Contract Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biosimilar Contract Manufacturing Market

34. Recent Developments In The Biosimilar Contract Manufacturing Market

35. Biosimilar Contract Manufacturing Market High Potential Countries, Segments and Strategies

35.1 Biosimilar Contract Manufacturing Market In 2029 - Countries Offering Most New Opportunities

35.2 Biosimilar Contract Manufacturing Market In 2029 - Segments Offering Most New Opportunities

35.3 Biosimilar Contract Manufacturing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Biosimilar Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Biosimilar Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Erythropoietin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Granulocyte Colony-Stimulating Factor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Biosimilar Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Biosimilar Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: Biocon Limited Financial Performance
  • Table 83: Lonza Group AG Financial Performance
  • Table 84: Samsung Biologics Co. Ltd. Financial Performance
  • Table 85: WuXi Biologics (Cayman) Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Biosimilar Contract Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Biosimilar Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Erythropoietin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Granulocyte Colony-Stimulating Factor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Biosimilar Contract Manufacturing Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Biosimilar Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Biosimilar Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Biosimilar Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Biosimilar Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Biosimilar Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: Biocon Limited Financial Performance
  • Figure 83: Lonza Group AG Financial Performance
  • Figure 84: Samsung Biologics Co. Ltd. Financial Performance
  • Figure 85: WuXi Biologics (Cayman) Inc. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Biopharmaceuticals Contract Manufacturing Global Market Report 2025 – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars), By Source (...

View Report

Medical Device Contract Manufacturing Global Market Report 2025 – By Device (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Endoscopy Devices, Ophthalmology Devices, Orthopedic De...

View Report

Food Contract Manufacturing Global Market Report 2025 – By Services (Manufacturing Services, Packaging Services, Research and Development Services), By Manufacturing Process (Dry Blending, Spray Drying, Extrusion) – Impa...

View Report

Nutraceutical Contract Manufacturing Services Global Market Report 2025 – By Product (Dietary Supplements, Functional Food And Beverages), By Dosage Form (Tablets, Capsules, Liquid Oral, Powder In Sachet Or Jar, Gummies,...

View Report

Biologics Contract Development Global Market Report 2025 – By Source (Microbial, Mammalian, Others Sources), By Indication (Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Ind...

View Report

Digital Biomanufacturing Global Market Report 2025 – By Type (Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types), By Types of Biologic (s) Manufactured (Antibodies, Cell And G...

View Report

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025 – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase I, Phase I...

View Report

Biosimilars Global Market Report 2025 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombin...

View Report

Frequently Asked Questions

Biosimilar contract manufacturing refers to the outsourcing of biosimilar drug production to specialized third-party manufacturers with advanced infrastructure, technical expertise, and regulatory experience. These manufacturers produce biosimilars, biologic medicines highly similar to approved reference biologics in terms of safety, efficacy, and quality. It enables biopharmaceutical companies to minimize production costs, ensure compliance, and accelerate time-to-market. For further insights on this market, request a sample here

The market major growth driver - Growing Prevalence Of Diabetes Fueling The Growth Of The Market Due To Rising Demand For Affordable Insulin And Biologic Therapies. For further insights on this market, request a sample here

The biosimilar contract manufacturing market size has grown rapidly in recent years. It will grow from $8.58 billion in 2024 to $9.94 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing patent expirations of reference biologics, rising healthcare cost containment by payers, growing acceptance of biosimilars among clinicians, increasing prevalence of chronic diseases, and rising demand for affordable biologic therapies. The biosimilar contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $17.66 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing off-patent expiries of monoclonal antibodies, growing biosimilar development pipelines, rising price pressures and tender-based procurement, increasing adoption of value-based reimbursement, and growing entry of small and mid-sized biopharma sponsors. Major trends in the forecast period include a shift towards single-use bioreactor technology advancements, continuous bioprocessing developments, process analytical technology adoption and innovations, artificial intelligence and machine learning applications in bioprocess optimization, and quality by design implementation expansion. For further insights on this market, request a sample here

The biosimilar contract manufacturing market covered in this report is segmented –
1) By Product Type: Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor, Other Product Types
2) By Service Type: Process Development, Analytical And Quality Control, Fill And Finish Operations, Packaging, Other Service Types
3) By Source: Mammalian, Non-mammalian
4) By Application: Oncology, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications
5) By End-Use: Pharmaceutical Companies, Biotech Companies Subsegments:
1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Insulin: Rapid Acting Insulin, Short Acting Insulin, Intermediate Acting Insulin, Long Acting Insulin, Premixed Insulin
3) By Erythropoietin: Alpha Erythropoietin, Beta Erythropoietin, Darbepoetin Alfa, Continuous Erythropoietin Receptor Activators
4) By Granulocyte Colony-Stimulating Factor: Filgrastim, Pegfilgrastim, Lenograstim, Long Acting Granulocyte Colony-Stimulating Factor
5) By Other Product Types: Interferons, Interleukins, Fusion Proteins, Enzyme Therapeutics, Hormonal Biologics For further insights on this market, request a sample here

North America was the largest region in the biosimilar contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimilar contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the biosimilar contract manufacturing market are Thermo Fisher Scientific Inc., Biocon Limited, Lonza Group AG, Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., Laboratorios Farmacéuticos Rovi S.A., Vetter Pharma-Fertigung GmbH & Co. KG, National Resilience Inc., Porton Pharma Solutions Co. Ltd., Syngene International Limited, Rentschler Biopharma SE, Boehringer Ingelheim International GmbH, Enzene Biosciences Ltd., Prestige Biologics Co. Ltd., Mabion S.A., HALIX B.V., BioConnection B.V., BioCina Pty Ltd, Mycenax Biotech Inc., Polpharma Biologics S.A. . For further insights on this market, request a sample here.

Major trends in this market include Single-Use Biomanufacturing Reduces Costs And Shortens Production Timelines. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Biosimilar Contract Manufacturing Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon